Pharma firms to be incentivised to develop new superbug drugs

The UK government is promising to incentivise pharmaceutical companies to develop “urgently needed” drugs to fight antimicrobial resistant (AMR) superbugs, with the health secretary warning “we are on the cusp of a world where a simple graze could be deadly”.

Article: The Guardian

Smart Innovations  

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!
Popup Plugin